Kenya has received an initial shipment of 21,000 starter doses of Lenacapavir, a long-acting injectable HIV pre-exposure prophylaxis (PrEP), marking a significant milestone in the country’s fight against new infections. Landmark Step in HIV Prevention The consignment was received by Director General for Health Dr. Patrick Amoth, who described Kenya’s…
